← Back to Clinical Trials
Recruiting NCT06758817

NCT06758817 The Triad of Nutrition, Intestinal Microbiota and Rheumatoid Arthritis (TASTY)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06758817
Status Recruiting
Phase
Sponsor Lisbon Academic Medical Center - Centro Académico de Medicina de Lisboa
Condition Diet Interventions
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2023-01-02
Primary Completion 2025-09-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
MedDiet+ interventionGeneral dietary recommendations

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2023-01-02 with a primary completion date of 2025-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The main goal of this trial is to investigate whether a dietary intervention based on a typical Mediterranean Diet enriched with fermented foods (MedDiet+) can impact gut microbiota and RA-related outcomes.

Eligibility Criteria

Inclusion Criteria: * RA patients (ACR/EULAR2010 criteria) * Age \>18-years * Disease duration \>1-year * Active disease (DAS28 \> 2.6units) * On stable medication for 12 weeks * Low/medium MedDiet adherence (PREDIMED\<10) * Willing to comply with study protocol Exclusion Criteria: * Prednisolone dose ≥ 7.5 mg/day * Antibiotic therapy 4-weeks prior to baseline * Persistent use of NSAID's * Inflammatory or irritable bowel disease * Celiac disease * Chronic diarrhea * Diabetes * Other immune-mediated inflammatory diseases besides RA * Major organ dysfunction * Cancer diagnosed in the last five years * Health conditions which may difficult participation (cognitive impairment/psychiatric disease) * Pregnant or lactating individuals

Contact & Investigator

Central Contact

Catarina Sousa Guerreiro, PhD

✉ cfguerreiro@medicina.ulisboa.pt

📞 +351 217 999 474

Principal Investigator

Catarina Sousa Guerreiro, RD PhD

PRINCIPAL INVESTIGATOR

Nutrition Lab, Faculty of Medicine, University of Lisbon

Frequently Asked Questions

Who can join the NCT06758817 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Diet Interventions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06758817 currently recruiting?

Yes, NCT06758817 is actively recruiting participants. Contact the research team at cfguerreiro@medicina.ulisboa.pt for enrollment information.

Where is the NCT06758817 trial being conducted?

This trial is being conducted at Lisbon, Portugal, Lisbon, Portugal.

Who is sponsoring the NCT06758817 clinical trial?

NCT06758817 is sponsored by Lisbon Academic Medical Center - Centro Académico de Medicina de Lisboa. The principal investigator is Catarina Sousa Guerreiro, RD PhD at Nutrition Lab, Faculty of Medicine, University of Lisbon. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology